Address

Excalibur Fund Managers Ltd
Berkeley Square
Berkeley Square House
London
W1J 6BD
United Kingdom

Open map

KANDO id: 32746

Corporate information

Official name
Excalibur Fund Managers Ltd
Registration country

Funds managed

Fund Type Vintage Currency Committed capital
Merlin Biosciences Fund III LP Venture 2003 EUR 139,000,000

Funding rounds

Investment preferences

Investment focus themes

Investment activity status
Not investing

Selected investments

Displaying 1 - 25 of 35
Profile Country Funding
Amura Ltd A structure-based drug discovery business specialising in diseases such as osteoporosis, osteoarthritis, bone metasta. Secondary sale in February 2005 N/A
Ardana PLC Drugs for reproductive disorders and hormone sensitive cancers. IPO in March 2005. N/A
Ark Therapeutics Group PLC Gene-based drugs for vascular and circulatory diseases and cancer. IPO in March 2004. N/A
Biovertis AG Hospital-acquired infections; respiratory tract infections; urinary tract infections. Acquired Morphochem AG in March 2006. N/A
Biowisdom Ltd Knowledge management software for drug development. N/A
Cambridge Biotechnology Ltd Small molecule drugs for pain and obesity. Aquired by Biovitrum AB in April 2005. N/A
Cyclacel Pharmaceutical Inc Cell cycle control drugs for cancer. IPO in January 2006. N/A
De Novo Pharmaceuticals Ltd A world leader in in-silico structure-based drug design, de novo drug design. N/A
Decon Sciences Ltd Decontamination services provider N/A
DestinationSkin Ltd Skin treatment and hair removal. N/A
Emergent BioSolutions Inc Research, development and manufacture of novel vaccines and related products IPO in November 2006. Fully disposed. N/A
Energist Ltd Manufactures and markets lasers and light-based systems for hair removal and aesthetic skin treatments, serving both the medical and beauty sectors. N/A
EpiCept Inc Topical pain management. IPO in January 2006. N/A
Intercytex Group PLC A UK Regenerative Medicine Company product and services. IPO in February 2006. Presently known as Regenerative Medicine Assets Ltd. N/A
KinderTec Ltd Paediatric consumer healthcare products. Trade sale in December 2005. N/A
Lab21 Ltd N/A
LiDCO Group PLC Researches, develops, manufactures and sells innovative medical devices. IPO in June 2004. N/A
Microscience Investments Ltd Vaccines for typhoid, travellers’ illnesses and hepatitis B Merged with NASDAQ listed Emergent Biosolutions Inc in July 2005. N/A
Neurotech Pharmaceuticals Inc (Neurotech Inc) Cell-based drugs for diseases of the eye. N/A
Noxxon Pharma AG Mirror image oligonucleotide drugs. N/A
Onyvax Ltd Whole-cell allogenic vaccines for cancer. Acquired by VaxOnco Inc. N/A
PanTherix Ltd A start-up biotech specializing in antibiotic target validation and drug discovery. N/A
Paradigm Therapeutics Ltd Drug discovery platform company Acquired by Takeda Pharmaceutical Company Ltd in December 2004. N/A
PIramed Pharma Ltd Oncology Therapeutics. Acquired by Roche in April 2008. N/A
Plethora Solutions Holdings PLC Discovering and developing urological products. IPO in March 2005. N/A

Current team

Selected Products / Customers

Financials